Evaluation of the surface-averaged load exerted on a blood element by the Reynolds shear stress field provided by artificial cardiovascular devices.

M. Grigioni,C. Daniele,G. D'Avenio,V. Barbaro

DOI: https://doi.org/10.1016/S0021-9290(02)00234-8

IF: 2.4

2002-12-01

Journal of Biomechanics

Abstract:

What problem does this paper attempt to address?

Mutational signatures and increased retrotransposon insertions in xeroderma pigmentosum variant skin tumors

Camila Corradi,Juliana B Vilar,Vanessa C Buzatto,Tiago A de Souza,Ligia P Castro,Veridiana Munford,Rodrigo De Vecchi,Pedro A F Galante,Fernanda Orpinelli,Thiago L A Miller,José L Buzzo,Mirian N Sotto,Paulo Saldiva,Jocelânio W de Oliveira,Sulamita C W Chaibub,Alain Sarasin,Carlos F M Menck

DOI: https://doi.org/10.1093/carcin/bgad030

2023-08-18

Carcinogenesis

Abstract:Xeroderma pigmentosum variant (XP-V) is an autosomal recessive disease with an increased risk of developing cutaneous neoplasms in sunlight-exposed regions. These cells are deficient in the translesion synthesis (TLS) DNA polymerase eta, responsible for bypassing different types of DNA lesions. From the exome sequencing of 11 skin tumors of a genetic XP-V patients' cluster, classical mutational signatures related to sunlight exposure, such as C>T transitions targeted to pyrimidine dimers, were identified. However, basal cell carcinomas also showed distinct C>A mutation spectra reflecting a mutational signature possibly related to sunlight-induced oxidative stress. Moreover, four samples carry different mutational signatures, with C>A mutations associated with tobacco chewing or smoking usage. Thus, XP-V patients should be warned of the risk of these habits. Surprisingly, higher levels of retrotransposon somatic insertions were also detected when the tumors were compared with non-XP skin tumors, revealing other possible causes for XP-V tumors and novel functions for the TLS polymerase eta in suppressing retrotransposition. Finally, the expected high mutation burden found in most of these tumors renders these XP patients good candidates for checkpoint blockade immunotherapy.
XPC deficiency increases risk of hematologic malignancies through mutator phenotype and characteristic mutational signature

Andrey A Yurchenko,Ismael Padioleau,Bakhyt T Matkarimov,Jean Soulier,Alain Sarasin,Sergey Nikolaev

DOI: https://doi.org/10.1038/s41467-020-19633-9

2020-11-17

Abstract:Recent studies demonstrated a dramatically increased risk of leukemia in patients with a rare genetic disorder, Xeroderma Pigmentosum group C (XP-C), characterized by constitutive deficiency of global genome nucleotide excision repair (GG-NER). The genetic mechanisms of non-skin cancers in XP-C patients remain unexplored. In this study, we analyze a unique collection of internal XP-C tumor genomes including 6 leukemias and 2 sarcomas. We observe a specific mutational pattern and an average of 25-fold increase of mutation rates in XP-C versus sporadic leukemia which we presume leads to its elevated incidence and early appearance. We describe a strong mutational asymmetry with respect to transcription and the direction of replication in XP-C tumors suggesting association of mutagenesis with bulky purine DNA lesions of probably endogenous origin. These findings suggest existence of a balance between formation and repair of bulky DNA lesions by GG-NER in human body cells which is disrupted in XP-C patients.
Xeroderma Pigmentosum: A Genetic Condition Skin Cancer Correlated-A Systematic Review

Tito Brambullo,Michele Rosario Colonna,Vincenzo Vindigni,Stefano Piaserico,Giuseppe Masciopinto,Mariarosaria Galeano,Alfio Luca Costa,Franco Bassetto

DOI: https://doi.org/10.1155/2022/8549532

2022-07-18

Abstract:Background: Xeroderma pigmentosum (XP) is a rare autosomal recessive disorder of UV radiation-induced damage repair that is characterized by photosensitivity and a propensity for developing, among many others, skin cancers at an early age. This systematic review focused on the correlation between the clinical, pathological, and genetic aspects of XP and skin cancer. Methods: A systematic review was conducted through a literature search of online databases PubMed, Cochrane Library, SciELO, and Google Scholar. Search terms were "Xeroderma pigmentosum", "XP", "XPC", "Nucleotide excision repair", "NER", "POLH", "Dry pigmented skin", and "UV sensitive syndrome" meshed with the terms "Skin cancer", "Melanoma", and "NMSC". Results: After 504 abstracts screening, 13 full-text articles were assessed for eligibility, and 3 of them were excluded. Ten articles were selected for qualitative assessment. Conclusions: Patients with XP usually suffer shorter lives due to skin cancer and neurodegenerative disease. Deletion/alteration of a distinct gene allele can produce different types of cancer. The XPC and XP-E variants are more likely to have skin cancer than patients in other complement groups, and the most common cause of death for these patients is skin cancer (metastatic melanoma or invasive SCC). Still, aggressive preventative measures to minimize UV radiation exposure can retard the course of the disease and improve the quality of life.
XPC beyond nucleotide excision repair and skin cancers

Abir Zebian,Abdullah Shaito,Frédéric Mazurier,Hamid Reza Rezvani,Kazem Zibara

DOI: https://doi.org/10.1016/j.mrrev.2019.108286

Abstract:Xeroderma pigmentosum group C (XPC) has been known as a DNA damage recognition factor of bulky adducts and as an initiator of global genome nucleotide excision repair (GG-NER). XP-C patients have been shown to have a predisposition to develop skin and certain internal cancers. Recent studies have shown that XPC presents several functional and molecular interactions with fundamental players in several other DNA repair pathways including base excision repair (BER). Furthermore, novel clues indicate that XPC is involved in transcription regulation in the cell. In this review, association between abnormal XPC activity as well as several XPC polymorphisms with the incidence of non-skin tumors is discussed. We also review the current literature regarding the roles of XPC in different DNA repair pathways, highlighting its tumor suppressor activity that may occur independently of its conventional function in NER. Deciphering the NER-independent involvement of XPC in onset and progress of non-skin cancers will have positive implications on prognosis and therapy of cancers with XPC deficiency.
XPC Polymorphism Increases Risk of Digestive System Cancers： Current Evidence from A Meta-Analysis

Xia Jiang,Li-tao Zhou,Shan-chun Zhang,Kun Chen

DOI: https://doi.org/10.1007/s11670-012-0181-0

2012-01-01

Chinese Journal of Cancer Research

Abstract:Xeroderma pigmentosum complementation group C (XPC) participates in the initial recognition of DNA damage during nucleotide excision repair process in global genomic repair. Our meta-analysis was performed to evaluate the association between three polymorphisms (Lys939Gln, PAT+/- and Ala499Val) of XPC gene and risk of digestive system cancers.
Increased risk of internal tumors in DNA repair-deficient xeroderma pigmentosum patients: analysis of four international cohorts

Sergey Nikolaev,Andrey A Yurchenko,Alain Sarasin

DOI: https://doi.org/10.1186/s13023-022-02203-1

2022-03-04

Abstract:Background: Xeroderma pigmentosum (XP) is a rare, autosomal, recessive DNA repair-deficiency disorder with a frequency of 1-3 per million livebirths in Europe and USA but with higher frequencies in isolated islands or in countries with a high level of consanguinity. XP is characterized by high incidence of skin cancers on sun-exposed sites. Recent improvement in life expectancy of XP patients suggests an increased risk of frequently aggressive and lethal internal tumors. Our purpose was to quantify relative risks of internal tumor development for XP patients by tumor type, XP-subtype, patients' ages and ethnicity through comparison with the US general population. Methods: We analyzed four independent international well-characterized XP cohorts (from USA, UK, France and Brazil) with a total of 434 patients, where 11.3% developed internal tumors and compared them to the American general population. We also compiled, through PubMed/Medline, a dataset of 89 internal tumors in XP patients published between 1958 and 2020. Results: In the combined 4-XP cohort, relative risk of internal tumors was 34 (95% confidence interval (CI) 25-47) times higher than in the general population (p-value = 1.0E-47) and tumor arose 50 years earlier. The XP-C group was at the highest risk for the 0-20 years old-patients (OR = 665; 95% CI 368-1200; p-value = 4.3E-30). The highest risks were observed for tumors of central nervous system (OR = 331; 95% CI 171-641; p-value = 2.4E-20), hematological malignancies (OR = 120; 95% CI 77-186; p-value = 3.7E-36), thyroid (OR = 74; 95% CI 31-179; p-value = 1.2E-8) and gynecological tumors (OR = 91; 95% CI 42-193; p-value = 3.5E-12). The type of mutation on the XPC gene is associated with different classes of internal tumors. The majority of French XP-C patients (80%) are originated from North Africa and carried the XPC delTG founder mutation specific from the South Mediterranean area. The OR is extremely high for young (0-20 years) patients with more than 1300-fold increase for the French XPs carrying the founder mutation. Conclusion: Because the age of XP population is increasing due to better sun-protection and knowledge of the disease, these results are of particular importance for the physicians to help in early prevention and detection of internal tumors in their XP patients. Few preventive blood analyses or simple medical imaging may help to better detect early cancer appearance in this population.
The French Cohort of DNA Repair-Deficient Xeroderma Pigmentosum Patients: Risk of Hematological Malignancies

Alain Sarasin

DOI: https://doi.org/10.3390/cancers15102706

2023-05-10

Abstract:Background: Xeroderma pigmentosum (XP) is a rare genetic disorder characterized by a high incidence of skin cancers. These patients are deficient in nucleotide excision repair caused by mutations in one of the 7 XP genes. Methods: We diagnosed 181 XP patients using UV-induced DNA repair measurements and/or DNA sequencing from 1982 to 2022 in France. Results: As all XP patients, the French ones are very sensitive to UV exposure but since they are usually very well protected, they develop relatively few skin cancers. A majority of French XP patients originate from North Africa and bear a founder mutation on the XPC gene. The striking discovery is that these patients are at a very high risk to develop aggressive and lethal internal tumors such as hematological malignancies (more than a 100-fold risk compared to the general population for myelodysplasia/leukemia) with a median age of death of 25 years, and brain, gynecological, and thyroid tumors with even lower median ages of death. The high mutation rates found in XP-C internal tumors allow us to think that these XP patients could be successfully treated by immunotherapies. A full analysis of the molecular origins of these DNA repair-deficient tumors is discussed. Several explanations for this high predisposition risk are proposed. Conclusions: As the age of the XP population is increasing due to better photo-protection, the risk of lethal internal tumors is a new Damocles sword that hangs over XP-C patients. This review of the French cohort is of particular importance for alerting physicians and families to the prevention and early detection of aggressive internal tumors in XP patients.
Development of effective skin cancer treatment and prevention in xeroderma pigmentosum

W Clark Lambert,Muriel W Lambert

DOI: https://doi.org/10.1111/php.12385

Abstract:Xeroderma pigmentosum (XP) is a rare, recessively transmitted genetic disease characterized by increasingly marked dyspigmentation and xerosis (dryness) of sun-exposed tissues, especially skin. Skin cancers characteristically develop in sun-exposed sites at very much earlier ages than in the general population; these are often multiple and hundreds or even thousands may develop. Eight complementation groups have been identified. Seven groups, XP-A…G, are associated with defective genes encoding proteins involved in the nucleotide excision DNA repair (NER) pathway that recognizes and excises mutagenic changes induced in DNA by sunlight; the eighth group, XP-V, is associated with defective translesion synthesis (TLS) bypassing such alterations. The dyspigmentation, xerosis and eventually carcinogenesis in XP patients appear to be due to their cells' failure to respond properly to these mutagenic DNA alterations, leading to mutations in skin cells. A subset of cases, especially those in some complementation groups, may develop neurological degeneration, which may be severe. However, in most XP patients, in the past the multiple skin cancers have led to death at an early age due to either metastases or sepsis. Using either topical 5-fluorouracil or imiquimod, we have developed a protocol that effectively prevents most skin cancer development in XP patients.
Taking Steps to Secure Web Services

DAVID D GEER

DOI: https://doi.org/10.1109/MC.2003.1236464

2003-10-01

Computer

Abstract:Despite the promise, Web services present network administrators with a thorny problem: as network security becomes an increasing concern, Web services open up networks by letting outside users access databases, applications, and internal users. Traditional security techniques - such as virtual private networks or secure sockets layer (SSL) technology - cannot secure the large number of transactions that Web services can perform in a short time. Meanwhile, basic Web services transactions are unencrypted and unsecured, which creates the potential for disaster. It is thus important for Web services technology to have its own security mechanisms. In fact, industry observers have said the biggest obstacle to wider adoption of Web services has been security concerns. With this in mind, researchers are developing and implementing several Web services security approaches.
Structure and dynamics of CO2 and N2 in a tetracyanoborate based ionic liquid.

Hongjun Liu,S. Dai,D. Jiang

DOI: https://doi.org/10.1039/c3cp54326a

2014-01-02

Abstract:To gain insight into the transport behavior of gas molecules such as CO2versus N2 through ionic liquid membranes, we performed molecular dynamics simulations to investigate the structure and dynamics of CO2 and N2 gases in a tetracyanoborate based ionic liquid recently shown to exhibit high CO2/N2 permselectivity. We found that upon addition of CO2 or N2 the liquid structure does not change. CO2 or N2 molecules occupy the voids between ions and their local environments are found to be similar. Gas diffusivity is about one order of magnitude greater than that of the cation or anion. Dissolved N2 diffuses slightly faster than CO2. We hence conclude that the high permeability selectivity of CO2versus N2 observed experimentally is mainly due to the disparity in gas solubility. In other words, the much higher solubility of CO2 in tetracyanoborate-based ionic liquids such as 1-ethyl-3-methylimidazolium tetracyanoborate [emimB(CN)4] leads to their high CO2 permeability. Based on the experimental solubility and the simulated diffusivity, we obtained a permeability of 2830 barrer for CO2 in emimB(CN)4 at 300 K, in good agreement with the experimental value of 2040 barrer.
Early-onset gynecological tumors in DNA repair-deficient xeroderma pigmentosum group C patients: a case series

Andrey A Yurchenko,Brice Fresneau,Bruno Borghese,Fatemeh Rajabi,Zora Tata,Catherine Genestie,Alain Sarasin,Sergey I Nikolaev

DOI: https://doi.org/10.1038/s43856-023-00341-6

2023-08-11

Abstract:Background: Xeroderma pigmentosum (XP) is a group of rare hereditary disorders with highly increased risk of skin tumors due to defective DNA repair. Recently we reported 34-fold increased risk of internal tumors in XP patients in comparison with general population. The molecular data and clinical practice on the internal tumors treatment in XP patients is limited and scarcely represented in the medical literature. In this work, we describe young patients with constitutive biallelic deactivation of the XPC gene developing gynecological tumors with somatic DICER1 mutations. Methods: Whole genome sequencing was used to analyze in detail somatic mutational landscape and driver events of these rare tumors. Results: We describe five early-onset gynecological tumors in four xeroderma pigmentosum group C (XP-C) young patients (11 to 19 years old) including vaginal embryonal rhabdomyosarcomas in monozygotic twin sisters, juvenile granulosa-cell tumor of the ovary and poorly differentiated stage IA Sertoli-Leydig cell tumor in 19-years old patient, and FIGO stage IC1 tumor of ovary in 13-years old patient. XP-C ovarian tumors harbor 4.4 times more single base substitutions than sporadic tissue-matched cancers and demonstrate XP-C specific mutation signature with strong transcriptional bias indicating inability of the cells to repair bulky DNA lesions of unknown etiology. A special mode of treatment was applied to avoid usage of chemotherapy which is toxic for XP patients. Conclusions: XP-C status should be accounted for prevention and specific treatment of gynecological tumors in young DNA repair-deficient XP patients.
Novel mutation identified in the DDB2 gene in patients with xeroderma pigmentosum group-E

Ebru Karagün,Recep Eroz,Mehmet Gamsızkan,Sevim Baysak,Yavuz Eyup,Yunus Ozcan

DOI: https://doi.org/10.1111/ijd.14957

Abstract:Background: Xeroderma pigmentosum (XP) is a rare photosensitive syndrome, which is divided into eight complementation groups (XP-A to XP-G and XPV) and characterized by skin cancers diagnosed at early age. A family of seven members (age range between 5 and 47 years) with carriers of the novel nonsense mutation that causes XP-E type were included in the current study. Methods: DNA was isolated from peripheral blood samples of the proband, and cancer predisposition genes were sequenced with next-generation sequencing. The demographic features and the laboratory, clinical, and histopathological findings of patients were evaluated. Results: In the proband, squamous cell carcinoma was first diagnosed in the right-eye cornea at the age of 13 years and then in the left-eye cornea at the age of 15 years. Later, the patient was diagnosed with basosquamous cell carcinoma on the dorsum of the nose at the age of 18 years. After genetic analysis, a novel nonsense c.1063C>T(p.Arg355Ter) pathogenic variation that causes XP-E type was detected as homozygous in the DDB2 gene of the proband and her siblings, 11 and 5 years of age, and as heterozygous in her parents and a 22-year-old brother. Conclusion: Because of the occurrence of early termination codon, truncated nonfunctional proteins or proteins with deleterious loss or gain-of-function activities are synthesized in nonsense mutation. Thus, to avoid the development of pathological lesions, it is important that such patients with nonsense mutation stay away from agents that might cause DNA damage and develop an appropriate lifestyle according to this condition.
Cloning and characterization of a general amino acid control transcriptional activator from the chestnut blight fungus Cryphonectria parasitica.

P. Wang,T. G. Larson,C. H. Chen,D. Pawlyk,J. A. Clark,D. Nuss

DOI: https://doi.org/10.1006/FGBI.1997.1023

IF: 3.883

1998-02-01

Fungal Genetics and Biology

Abstract:We have cloned and characterized a homologue of the Neurospora crassa general amino acid control gene cpc-1 from the chestnut blight fungus Cryphonectria parasitica. The deduced amino acid sequence of C. parasitica CPC1 (cpCPC1) contains regions with significant homology to the transcriptional activation, DNA binding, and dimerization domains previously defined for N. crassa CPC1 (ncCPC1) and the equivalent "b-ZIP" transcription factor from Saccharomyces cerevisiae, GCN4 (scGCN4). Treatment of C. parasitica with low levels of the protein synthesis inhibitor cycloheximide caused cpc-1 transcript levels to undergo a rapid, transient increase similar to that reported for the mammalian b-ZIP transactivators, c-Jun and c-Fos. Northern analysis also revealed that amino acid starvation of C. parasitica elicits an increase in cpc-1 transcript levels. Hypovirus infection did not affect this increase, although transcript accumulation for several amino acid biosynthetic genes was slightly diminished in the hypovirus-containing strain. Recombinant cpCPC1 specifically bound to the consensus DNA binding element (AP-1), 5'-A/GTGACTCAT-3', also located upstream of the C. parasitica cpc-1 coding region. Constitutive transgenic expression of a DNA binding defective cpCPC1 mutant impaired the ability of C. parasitica to adjust to amino acid starvation. Moreover, these transformants showed reduced ability to grow on host chestnut tissue. Our results define a general amino acid control transactivator in a plant pathogenic fungus and suggest that functional modulation of this factor can influence fungal virulence.
Female hirsutism: study of chromatography of 17-ketosteroids.

R. Bolinger,R. Schrepfer

1958-12-01

Abstract:
Review clears Brompton surgeons

G. Yamey

DOI: https://doi.org/10.1136/BMJ.319.7212.729A

1999-09-18

British Medical Journal

Abstract:A review of the surgical outcomes at the Royal Brompton Hospital has cleared the hospital over allegations of excessive mortality in children undergoing cardiac surgery. The independent review of paediatric surgery, comprising paediatric consultant cardiologists Dr Stewart Hunter and Dr Michael Godman and consultant cardiac surgeon Mr James Monro, studied operative data from 1987 to 1999 and found that “the Brompton results are similar to, and in most cases better than, the results from the UK register.” The data, sent by an anonymous whistleblower to Private Eye magazine, were “incomprehensible, incomplete, and misleading.” Private Eye, which did not publish the allegations, passed the data, in confidence, to Mark Taylor, chief executive of the Brompton …
Xeroderma Pigmentosum: General Aspects and Management

Monica Piccione,Anna Belloni Fortina,Giulia Ferri,Gloria Andolina,Lorenzo Beretta,Andrea Cividini,Emanuele De Marni,Francesca Caroppo,Ugo Citernesi,Rosa Di Liddo

DOI: https://doi.org/10.3390/jpm11111146

2021-11-04

Abstract:Xeroderma Pigmentosum (XP) is a rare genetic syndrome with a defective DNA nucleotide excision repair. It is characterized by (i) an extreme sensitivity to ultraviolet (UV)-induced damages in the skin and eyes; (ii) high risk to develop multiple skin tumours; and (iii) neurologic alterations in the most severe form. To date, the management of XP patients consists of (i) early diagnosis; (ii) a long-life protection from ultraviolet radiation, including avoidance of unnecessary UV exposure, wearing UV blocking clothing, and use of topical sunscreens; and (iii) surgical resections of skin cancers. No curative treatment is available at present. Thus, in the last decade, in order to prevent or delay the progression of the clinical signs of XP, numerous strategies have been proposed and tested, in some cases, with adverse effects. The present review provides an overview of the molecular mechanisms featuring the development of XP and highlights both advantages and disadvantages of the clinical approaches developed throughout the years. The intention of the authors is to sensitize scientists to the crucial aspects of the pathology that could be differently targeted. In this context, the exploration of the process underlining the conception of liposomal nanocarriers is reported to focus the attention on the potentialities of liposomal technology to optimize the administration of chemoprotective agents in XP patients.
XPC and POLH/XPV Genes Mutated in a Genetic Cluster of Xeroderma Pigmentosum Patients in Northeast Brazil

Ligia Pereira Castro,Danilo Batista-Vieira,Tiago Antonio de Souza,Ana Rafaela de Souza Timoteo,Jessica Dayanna Landivar Coutinho,Isabel Cristina Pinheiro de Almeida,Sheila Ramos de Miranda Henriques,Fabio Medeiros de Azevedo,Reginaldo Cruz Alves Rosa,Patricia L Kannouche,Alain Sarasin,Carlos Frederico Martins Menck,Tirzah Braz Petta

DOI: https://doi.org/10.3389/fgene.2021.784963

2022-01-17

Abstract:Xeroderma pigmentosum (XP) is a rare genetic condition in which exposure to sunlight leads to a high tumor incidence due to defective DNA repair machinery. Herein, we investigated seven patients clinically diagnosed with XP living in a small city, Montanhas (Rio Grande do Norte), in the Northeast region of Brazil. We performed high-throughput sequencing and, surprisingly, identified two different mutated genes. Six patients carry a novel homozygote mutation in the POLH/XPV gene, c.672_673insT (p.Leu225Serfs*33), while one patient carries a homozygote mutation in the XPC gene, c.2251-1G>C. This latter mutation was previously described in Southeastern Africa (Comoro Island and Mozambique), Pakistan, and in a high incidence in Brazil. The XP-C patient had the first symptoms before the first year of life with aggressive ophthalmologic tumor progression and a melanoma onset at 7 years of age. The XP-V patients presented a milder phenotype with later onset of the disorder (mean age of 16 years old), and one of the six XP-V patients developed melanoma at 72 years. The photoprotection is minimal among them, mainly for the XP-V patients. The differences in the disease severity between XP-C (more aggressive) and XP-V (milder) patients are obvious and point to the major role of photoprotection in the XPs. We estimate that the incidence of XP patients at Montanhas can be higher, but with no diagnosis, due to poor health assistance. Patients still suffer from the stigmatization of the condition, impairing diagnosis, education for sun protection, and medical care.
High Frequency of PTEN Mutations in Nevi and Melanomas from Xeroderma Pigmentosum Patients.

Taro Masaki,Yun Wang,John J DiGiovanna,Sikandar G Khan,Mark Raffeld,Senda Beltaifa,Thomas J Hornyak,Thomas N Darling,Chyi-Chia R Lee,Kenneth H Kraemer

DOI: https://doi.org/10.1111/pcmr.12226

2014-01-01

Pigment Cell & Melanoma Research

Abstract:SummaryWe examined nevi and melanomas in 10 xeroderma pigmentosum (XP) patients with defective DNA repair. The lesions had a lentiginous appearance with markedly increased numbers of melanocytes. Using laser capture microdissection, we performed DNA sequencing of 18 benign and atypical nevi and 75 melanomas (melanoma in situ and invasive melanomas). The nevi had a similar high frequency of PTEN mutations as melanomas [61% (11/18) versus 53% (39/73)]. Both had a very high proportion of UV‐type mutations (occurring at adjacent pyrimidines) [91% (10/11) versus 92% (36/39)]. In contrast to melanomas in the general population, the frequency of BRAF mutations (11%, 7/61), NRAS mutations (21%, 13/62), and KIT mutations (21%, 6/28) in XP melanomas was lower than for PTEN. Phospho‐S6 immunostaining indicated activation of the mTOR pathway in the atypical nevi and melanomas. Thus, the clinical and histological appearances and the molecular pathology of these UV‐related XP nevi and melanomas were different from nevi and melanomas in the general population.
Übo 2.a . . Edge Decompositions of the Complete Graph into Copies of a Connected Subgraph

P. Erdos,J. Schbnheim

Abstract:Necessary and tions on (n,k,Y..) are given for the posA hi1it_r to partition the edges of the complete graph K l into isomorphic copies of a connected suhgraph Gk 2 with k vertices and t edges. It is conjectured that these conditions are sufficient if n is large. This conjecture is proved for 2, 3 and 4 .
Molecular analysis of glioma and skin-tumour alterations in a xeroderma-pigmentosum child

G Giglia,E Bouffet,A Jouvet,H Ohgaki,P Kleihues,A Sarasin

DOI: https://doi.org/10.1002/(sici)1097-0215(19990505)81:3<345::aid-ijc6>3.0.co;2-e

1999-05-05

Abstract:Xeroderma pigmentosum (XP) is a rare hereditary disease characterized by a very high frequency of skin tumours due to a defect in the nucleotide-excision-repair process. Some of these patients have also been reported to develop internal tumours with higher frequency than the normal population. Reported here are the clinical features and molecular analysis of an XP patient who developed multiple skin cancers as well as a thalamic glioma. Complementation analysis with recombinant retrovirus, cloning efficiency and unscheduled DNA synthesis after UV-C indicate that the patient belongs to the C group. Characterization of the p53 mutations in the 2 tumours of the patient leads to speculation on the aetiological agents involved in tumour initiation. The skin tumour is clearly induced by the presence of unrepaired UVB-induced DNA damage on the non-transcribed strand of the p53 gene, while the glioma may be induced by unrepaired DNA lesions produced by free radicals.

Evaluation of the surface-averaged load exerted on a blood element by the Reynolds shear stress field provided by artificial cardiovascular devices.

Mutational signatures and increased retrotransposon insertions in xeroderma pigmentosum variant skin tumors

XPC deficiency increases risk of hematologic malignancies through mutator phenotype and characteristic mutational signature

Xeroderma Pigmentosum: A Genetic Condition Skin Cancer Correlated-A Systematic Review

XPC beyond nucleotide excision repair and skin cancers

XPC Polymorphism Increases Risk of Digestive System Cancers： Current Evidence from A Meta-Analysis

Increased risk of internal tumors in DNA repair-deficient xeroderma pigmentosum patients: analysis of four international cohorts

The French Cohort of DNA Repair-Deficient Xeroderma Pigmentosum Patients: Risk of Hematological Malignancies

Development of effective skin cancer treatment and prevention in xeroderma pigmentosum

Taking Steps to Secure Web Services

Structure and dynamics of CO2 and N2 in a tetracyanoborate based ionic liquid.

Early-onset gynecological tumors in DNA repair-deficient xeroderma pigmentosum group C patients: a case series

Novel mutation identified in the DDB2 gene in patients with xeroderma pigmentosum group-E

Cloning and characterization of a general amino acid control transcriptional activator from the chestnut blight fungus Cryphonectria parasitica.

Female hirsutism: study of chromatography of 17-ketosteroids.

Review clears Brompton surgeons

Xeroderma Pigmentosum: General Aspects and Management

XPC and POLH/XPV Genes Mutated in a Genetic Cluster of Xeroderma Pigmentosum Patients in Northeast Brazil

High Frequency of PTEN Mutations in Nevi and Melanomas from Xeroderma Pigmentosum Patients.

Übo 2.a . . Edge Decompositions of the Complete Graph into Copies of a Connected Subgraph

Molecular analysis of glioma and skin-tumour alterations in a xeroderma-pigmentosum child